Parallax Volatility Advisers
LJPC

Parallax Volatility Advisers’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Parallax Volatility Advisers’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,700
Closed -$216K – 5515
2017
Q4 		$216K Sell
6,700
-64,200
-91% -$2.1M ﹤0.01% 2223
2017
Q3 		$2.47M Buy
+70,900
New +$2.28M ﹤0.01% 784

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Parallax Volatility Advisers's LJPC Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2018, closing a stake of 4,918 shares — an estimated $158K sold.

Parallax Volatility Advisers first reported a position in LJPC in Q1 2017 and held it in 3 quarters. The position peaked at $655K in Q3 2017. 100 funds tracked by Wall St. Rank hold LJPC as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining La Jolla Pharmaceutical Company position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,918 La Jolla Pharmaceutical Company shares in Q1 2018, an estimated $158K.
  • Parallax Volatility Advisers first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's La Jolla Pharmaceutical Company position peaked at $655K in Q3 2017.
  • 100 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.